IEA Health Delegation Meets FUJIFILM Health Care Representatives to Discuss Advanced Medical Technologies

rasooli_admin
Mon, Dec 01 2025 11:55 AM
MOPH

The Deputy Minister for Healthcare Services at the Ministry of Public Health, Mawlawi Abdul Wali Haqqani, together with the Director-General of Chief of Staff, Sheikh Mohammad Tahir Haleem, and the accompanying delegation, held a meeting with representatives of FUJIFILM Health Care, a leading international Japanese company, during their visit to Turkey.

During the meeting, the company’s representatives delivered a comprehensive presentation on their advanced MRI, CT-scan, ultrasound, radiation oncology, and endoscopy technologies. The Deputy Minister described these state-of-the-art diagnostic devices as essential for strengthening the health system and delivering standardized, high-quality services. He further emphasized that accurate and timely diagnosis significantly reduces treatment costs, prevents complications, and enhances the overall quality of healthcare. He stressed that it is therefore crucial to equip the country’s health system and hospitals with modern medical technologies.

Latest news

Fri, Oct 16 2026 11:38 AM
Background image

Mawlawi Abdul Qadeer Nazir Appointed as Director of Procurement of the Ministry of Public Health

Qari Abdul Wali Siddiqi, Deputy Minister of Finance and Administration Affairs of the Ministry of Public Health, formally introduced Mawlawi Abdul Qadeer Nazir as the newly appointed. . .

Tue, Oct 13 2026 2:49 PM
Background image

Two Advanced X-Ray Machines Provided to Provincial Hospitals in Ghazni and Badghis

Equipped with advanced technology, the machines were procured to improve the quality of healthcare services, facilitate the accurate and timely diagnosis of diseases, and strengthen. . .

Tue, Oct 13 2026 2:12 PM
Background image

Afghanistan Food and Drug Authority (AFDA) Holds Administrative Meeting

The AFDA held an administrative meeting chaired by Mawlawi Hamdullah Zahid, Deputy Minister for Food and Drug Affairs, and attended by directors of the relevant pharmaceutical. . .

BACK TO NEWS